WCLC 2022 Conference Coverage


 

WCLC 2022 on the NADIM II Trial: Pre-Treatment ctDNA Levels Significantly Predict OS & PFS in Locally Advanced & Potentially Resectable NSCLC

92 views
August 18, 2022
Comments 0
Login to view comments. Click here to Login